2020
DOI: 10.1007/s13238-020-00736-4
|View full text |Cite
|
Sign up to set email alerts
|

Broad spectrum antibiotic-degrading metallo-β-lactamases are phylogenetically diverse

Abstract: Broad spectrum antibiotic-degrading metalloβ-lactamases are phylogenetically diverse Dear Editor,

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
43
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 22 publications
(61 citation statements)
references
References 15 publications
3
43
0
Order By: Relevance
“…In summary, we previously demonstrated that marine environments harbour a large number of MBLs from the B3 subgroup 42 . Of particular interest among those MBLs are those from the marine organisms N. pentaromativorans (MIM-1) and S. agarivorans (SAM-1, formerly known as MIM-2) as we previously already demonstrated that they are not only potent MBLs, but are also capable to hydrolyze quorum-sensing molecules 20 , 21 .…”
Section: Resultsmentioning
confidence: 65%
See 2 more Smart Citations
“…In summary, we previously demonstrated that marine environments harbour a large number of MBLs from the B3 subgroup 42 . Of particular interest among those MBLs are those from the marine organisms N. pentaromativorans (MIM-1) and S. agarivorans (SAM-1, formerly known as MIM-2) as we previously already demonstrated that they are not only potent MBLs, but are also capable to hydrolyze quorum-sensing molecules 20 , 21 .…”
Section: Resultsmentioning
confidence: 65%
“…The zinc binding sites in MIM-1 and SAM-1 (Fig. 2) are defined by a motif (HHH/DHH), that is characteristic for the majority of MBLs of the B3 subgroup 42 . The Zn-Zn distances in MIM-1 (4.02 Å) and SAM-1 (3.40 Å) are comparable with those observed in other B3 MBLs, i.e.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, there are marked differences between these two types of enzymes, both in the mechanism of action and the structural topology, which hinders the development of effective inhibitors based on previous scaffolds. [ 60,64–66 ]…”
Section: Carbapenemases: the Nightmare Of Anti‐infective Therapies Based On β‐Lactam Antibioticsmentioning
confidence: 99%
“…Thus, there are marked differences between these two types of enzymes, both in the mechanism of action and the structural topology, which hinders the development of effective inhibitors based on previous scaffolds. [60,[64][65][66] Nowadays, there is a great deal of concern about the impact of the infections caused by carbapenem-resistant A. baumannii, P. aeruginosa, and Enterobacteriaceae that are frequently found in hospitalized patients fitted with invasive devices or exposed to extended antibiotic regimens. [67][68][69][70] Of particular concern is the global incidence of class A carbapenemases, such as KPC, SME, IMI, NMC-A, and GES-2, carbapenem-hydrolyzing class D -lactamases, such as OXA-23, OXA-24/40, and OXA-48, as well as metallo--lactamases such as IMP, VIM, and NDM (Figure 4).…”
Section: Carbapenemases: the Nightmare Of Anti-infective Therapies Based On -Lactam Antibioticsmentioning
confidence: 99%